Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Pfizer
Tizona Therapeutics, Inc
Essen Biotech
University of Nebraska
Second Life Therapeutics
Elephas
Novartis
Elephas
University of Pittsburgh
AstraZeneca
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
7 Hills Pharma, LLC
Washington University School of Medicine
Fudan University
Institut Claudius Regaud
Genentech, Inc.
DEKA Biosciences
Columbia University
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie